Ventec’s FDA-cleared VOCSN solution is the first and only multifunctional ventilator that integrates a critical care ventilator, oxygen concentrator, cough assist, suction and nebulizer into a single portable device.

Under the agreement with Ventec, GM will revamp its Indiana car parts plant with equipment needed to produce VOCSN critical care ventilators. It will deploy an estimated 1,000 U.S. workers to scale production immediately.


The companies are adding thousands of units of new capacity with a significantly expanded supply chain capable of supporting high volume production. The two have worked across manufacturing, engineering, purchasing and legal requirements to create and implement a plan for immediate, scaled production of critical care ventilators, with both companies’ global supply base developing sourcing plans for more than 700 individuals parts needed to build up to 200,000 VOCSN.

Depending on the needs of the federal government, Ventec and GM are prepared to deliver the first ventilators next month and ramp up production capacity to more than 10,000 ventilators per month, with the infrastructure and capability to scale further.

"GM is in the position to help build more ventilators because of the remarkable performance of GM and Ventec's global supply base," said Mary Barra, GM chairman and CEO, in a statement. "Our joint teams have moved mountains to find real solutions to save lives and fight the pandemic."

Following his tweet about GM, Trump issued an order commanding GM to “accept, perform, and prioritize Federal contracts for ventilators” and accusing the automaker of “wasting time”.

“Our negotiations with GM regarding its ability to supply ventilators have been productive, but our fight against the virus is too urgent to allow the give-and-take of the contracting process to continue to run its normal course. GM was wasting time,” he said in a statement. “Today’s action will help ensure the quick production of ventilators that will save American lives.”

In addition to ventilator production, GM will also produce Level 1 FDA approved surgical masks at its factory in Michigan, and plans to ramp up production within two weeks to 50,000 masks per day, with the potential to increase to 100,000 daily.

Mask production is set to begin this week. Ventilators are set to ship out in April.

Back to HCB News

U.S. Healthcare Homepage